Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Recurrence 1Glioma 1Colorectal Adenocarcinoma 1Brain Neoplasms 1Anxiety Disorders 1

Interventions

Oxaliplatin 2Leucovorin 2Irinotecan 2Fluorouracil 2Bevacizumab 2Temozolomide 1Nivolumab 1Fluoxetine 1Cisplatin 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colorectal Adenocarcinoma × Fluoxetine × 1 year × Clear all
NCT06225011 2026-05-11

Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer

Jonsson Comprehensive Cancer Center

Phase 1 Recruiting
10 enrolled
Gastrointestinal

Colorectal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡